ConductScience.org, home

Paper31372011

Efficacy of combinations of colistin with other antimicrobials involves membrane fluidity and efflux machinery.

Armengol E and 6 others. Infect Drug Resist, 2019. Cited by 29 papers, by iCite.

Cite this record

ConductScience Library. Efficacy of combinations of colistin with other antimicrobials involves membrane fluidity and efflux machinery. Papers, record 31372011. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31372011

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficacy of combinations of colistin with other antimicrobials involves membrane fluidity and efflux machinery.
PubMed
Journal
Infect Drug Resist
PubMed
Year
2019
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
29
iCite
Relative citation ratio, by iCite
1.93
iCite
Revised in PubMed
2022-04-09
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Armengol EE
2Domenech OO
3Fusté EE
4Pérez-Guillén II
5Borrell JHJ H
6Sierra JMJ M
7Vinas MM

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110585202Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin.J Med Chem1999https://conductscience.org/library/papers/10585202PubMed
215182931Cytoplasmic membrane polarization in Gram-positive and Gram-negative bacteria grown in the absence and presence of tetracycline.Biochim Biophys Acta2004https://conductscience.org/library/papers/15182931PubMed
317628643Fluorescence polarization in studies of bacterial cytoplasmic membrane fluidity under environmental stress.Prog Biophys Mol Biol2007https://conductscience.org/library/papers/17628643PubMed
421114395Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing.Pharmacotherapy2010https://conductscience.org/library/papers/21114395PubMed
521393131In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii.J Antimicrob Chemother2011https://conductscience.org/library/papers/21393131PubMed
621502628In vivo efficacy of glycopeptide-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection.Antimicrob Agents Chemother2011https://conductscience.org/library/papers/21502628PubMed
722351659Screening for efflux pump systems of bacteria by the new acridine orange agar method.In Vivo2012https://conductscience.org/library/papers/22351659PubMed
825055029In vitro synergistic activity of colistin and ceftazidime or ciprofloxacin against multidrug-resistant clinical strains of Pseudomonas aeruginosa.Microb Drug Resist2014https://conductscience.org/library/papers/25055029PubMed
925229285Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii.Rev Soc Bras Med Trop2014https://conductscience.org/library/papers/25229285PubMed
1025465524In vitro synergy of polymyxins with other antibiotics for Acinetobacter baumannii: a systematic review and meta-analysis.Int J Antimicrob Agents2015https://conductscience.org/library/papers/25465524PubMed
1125697677Colistin, mechanisms and prevalence of resistance.Curr Med Res Opin2015https://conductscience.org/library/papers/25697677PubMed
1226023209Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two 'old' antibiotics-polymyxin B and chloramphenicol.J Antimicrob Chemother2015https://conductscience.org/library/papers/26023209PubMed
1326906264Enhanced efficacy of imipenem-colistin combination therapy against multiple-drug-resistant Enterobacter cloacae: in vitro activity and a Galleria mellonella model.J Microbiol Immunol Infect2018https://conductscience.org/library/papers/26906264PubMed
1427503996Polymyxin: Alternative Mechanisms of Action and Resistance.Cold Spring Harb Perspect Med2016https://conductscience.org/library/papers/27503996PubMed
1527573251Colistin: still a lifesaver for the 21st century?Expert Opin Drug Metab Toxicol2017https://conductscience.org/library/papers/27573251PubMed
1627626405Synergistic Antipseudomonal Effects of Synthetic Peptide AMP38 and Carbapenems.Molecules2016https://conductscience.org/library/papers/27626405PubMed
1727865626Synergistic combinations of polymyxins.Int J Antimicrob Agents2016https://conductscience.org/library/papers/27865626PubMed
1828368216An overview of antimicrobial peptides and the latest advances in their development.Expert Opin Biol Ther2017https://conductscience.org/library/papers/28368216PubMed
1928489819Predictive compound accumulation rules yield a broad-spectrum antibiotic.Nature2017https://conductscience.org/library/papers/28489819PubMed
2028895051Polymyxin Resistance in Gram-negative Pathogens.Curr Infect Dis Rep2017https://conductscience.org/library/papers/28895051PubMed

See all 26 referencesDownload CSV of references

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.

PMIDTitleJournalYearIn PapersSource
42536331Investigation of the effects of ampicillin and ceftazidime on Proteus mirabilis using metabolomic approaches and bioinformatics analyses.Folia Microbiol (Praha)2026https://conductscience.org/library/papers/42536331PubMed
41908396Short Antimicrobial Peptides Based on Arginine and Tryptophan: Agents with Potential in Combating Resistant Pathogens.ACS Omega2026https://conductscience.org/library/papers/41908396PubMed
41044168A novel role for colistin as an efflux pump inhibitor in multidrug-resistant Klebsiella pneumoniae.Sci Rep2025https://conductscience.org/library/papers/41044168PubMed
39473844Prevalence of colistin resistance in clinical isolates of Pseudomonas aeruginosa: a systematic review and meta-analysis.Front Microbiol2024https://conductscience.org/library/papers/39473844PubMed
388920711,3,5-Triazine as Branching Connector for the Construction of Novel Antimicrobial Peptide Dendrimers: Synthesis and Biological Characterization.Int J Mol Sci2024https://conductscience.org/library/papers/38892071PubMed
38283226Development of pharmacophore models for AcrB protein and the identification of potential adjuvant candidates for overcoming efflux-mediated colistin resistance.RSC Med Chem2024https://conductscience.org/library/papers/38283226PubMed
37762115The Properties of Linezolid, Rifampicin, and Vancomycin, as Well as the Mechanism of Action of Pentamidine, Determine Their Synergy against Gram-Negative Bacteria.Int J Mol Sci2023https://conductscience.org/library/papers/37762115PubMed
37630679Native Pig Neutrophil Products: Insights into Their Antimicrobial Activity.Microorganisms2023https://conductscience.org/library/papers/37630679PubMed
37125928When Combined with Pentamidine, Originally Ineffective Linezolid Becomes Active in Carbapenem-Resistant Enterobacteriaceae.Microbiol Spectr2023https://conductscience.org/library/papers/37125928PubMed
37064006In vitro synergistic interaction of colistin and other antimicrobials against intrinsic colistin-resistant Morganella morganii isolates.3 Biotech2023https://conductscience.org/library/papers/37064006PubMed
36856424Colistin Enhances Rifampicin's Antimicrobial Action in Colistin-Resistant Pseudomonas aeruginosa Biofilms.Antimicrob Agents Chemother2023https://conductscience.org/library/papers/36856424PubMed
36675027Rejuvenating the Activity of Usual Antibiotics on Resistant Gram-Negative Bacteria: Recent Issues and Perspectives.Int J Mol Sci2023https://conductscience.org/library/papers/36675027PubMed
36578509Advances and perspectives for antimicrobial peptide and combinatory therapies.Front Bioeng Biotechnol2022https://conductscience.org/library/papers/36578509PubMed
35859215Cationic polymer contributes to broaden the spectrum of vancomycin activity achieving eradication of Pseudomonas aeruginosa.Arch Microbiol2022https://conductscience.org/library/papers/35859215PubMed
35745552Mobile Colistin Resistance (mcr) Genes in Cats and Dogs and Their Zoonotic Transmission Risks.Pathogens2022https://conductscience.org/library/papers/35745552PubMed
34660671Antimicrobial Peptides in Gut Health: A Review.Front Nutr2021https://conductscience.org/library/papers/34660671PubMed
34648177Contemporary Perspective on the Treatment of Acinetobacter baumannii Infections: Insights from the Society of Infectious Diseases Pharmacists.Infect Dis Ther2021https://conductscience.org/library/papers/34648177PubMed
34603057Synergistic Activity of Capsaicin and Colistin Against Colistin-Resistant Acinetobacter baumannii: In Vitro/Vivo Efficacy and Mode of Action.Front Pharmacol2021https://conductscience.org/library/papers/34603057PubMed
34204647New Trimethoprim-Like Molecules: Bacteriological Evaluation and Insights into Their Action.Antibiotics (Basel)2021https://conductscience.org/library/papers/34204647PubMed
33672685Attacins: A Promising Class of Insect Antimicrobial Peptides.Antibiotics (Basel)2021https://conductscience.org/library/papers/33672685PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31372011

GET https://conductscience.org/api/papers/v1/31372011/references?page=2